openPR Logo
Press release

Cytokine Market Global Report 2022-2027: Industry Size, Share, Trends, Growth and Forecast

08-18-2022 02:15 PM CET | Health & Medicine

Press release from: IMARC Group

Cytokine Market Global Report 2022-2027: Industry Size, Share,

The latest research study "Cytokine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" by IMARC Group, finds that the global cytokine market size reached US$ 76.67 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 121.25 Billion by 2027 exhibiting a CAGR of 7.80% during 2022-2027.

Covid-19 Impact:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Download free sample brochure: https://www.imarcgroup.com/cytokine-market/requestsample

Industry Definition and Application:

Cytokine is a class of proteins, peptides, or glycoproteins produced by specific cells that regulate the growth and activity of other blood and immune system cells. Since it has high-affinity picomolar concentrations, it helps control immunity, inflammation, and hematopoiesis. It is usually injected into veins, muscles, or under the skin to treat cancer and prevent or manage chemotherapy side effects. In recent years, cytokine has gained immense traction in immune cell differentiation, angiogenesis, tumorigenesis, neurobiology, and viral pathogenesis as it acts as diagnostic, prognostic, and therapeutic agents and biomarkers for health and diseases.

Cytokine Market Trends and Drivers:

The global cytokine market is primarily driven by the recent outbreak of the coronavirus disease (Covid-19), which induces the excessive production of pro-inflammatory cytokines resulting in tissue damage and acute respiratory distress syndrome (ARDS) aggravation. This has strengthened the need for solutions that target cytokines for better patient management, improved survival rates, and reduced mortality, as tissue damage can lead to multiple organ failures and even death.

Additionally, there has been a significant shift toward minimally invasive surgeries (MIS) due to their faster recovery time and lesser post-operative pain and complications. In line with this, the surging prevalence of atopic dermatitis (AD), a chronic, inflammatory, and recurring skin disease, has catalyzed the demand for new cytokines in the pathogenesis of AD and the development of improved therapeutic targets.

Other factors, including the rising incidences of cancer and skin disorders, ongoing research and development (R&D) activities, and continual technological advancements, are also anticipated to propel the market growth.

Click here to view detailed information with table of content: https://www.imarcgroup.com/cytokine-market

Report Segmentation:

The report has been segmented the market into following categories:

Breakup by Cytokine Type:
• Tumor Necrosis Factor-TNF
• Interleukins-Il
• Interferons-IFN
• Epidermal Growth Factor-EGF
• Others

Breakup by Therapeutic Application:
• Cancer
• Asthma and Airway Inflammation
• Arthritis
• Others

Breakup by End User:
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Academic and Research Institutes

Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

List of Major Key Players:

The major players in the market are AbbVie Inc., Abcam plc, Amgen Inc., Applied Biological Materials Inc. (abm), Bio-Techne Corporation, F. Hoffmann-La Roche AG, GenScript Biotech Corporation, Randox Laboratories Ltd., Thermo Fisher Scientific Inc. and UCB S.A.

Also, Read Latest Research Reports by IMARC Group:

Residential Washing Machine Market Report: https://www.imarcgroup.com/residential-washing-machine-market

Location-Based Services (LBS) Market Forecast: https://www.imarcgroup.com/location-based-services-market

Food Coating Ingredients Market Trend 2022-27: https://www.imarcgroup.com/food-coating-ingredients-market

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cytokine Market Global Report 2022-2027: Industry Size, Share, Trends, Growth and Forecast here

News-ID: 2708585 • Views:

More Releases from IMARC Group

GCC Pet Food Market Size is Expected to Reach USD 422.9 Million By 2033 | CAGR: 5.3%
GCC Pet Food Market Size is Expected to Reach USD 422.9 Million By 2033 | CAGR: …
GCC Pet Food Market Overview Market Size in 2024: USD 266.2 Million Market Size in 2033: USD 422.9 Million Market Growth Rate 2025-2033: 5.3% According to IMARC Group's latest research publication, "GCC Pet Food Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC pet food market size was valued at USD 266.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 422.9 Million by 2033, exhibiting a
GCC Residential Real Estate Market Size to Worth USD 147.77 Billion by 2033 | With a 7.50% CAGR
GCC Residential Real Estate Market Size to Worth USD 147.77 Billion by 2033 | Wi …
GCC Residential Real Estate Market Overview Market Size in 2024: USD 73.31 Billion Market Size in 2033: USD 147.77 Billion Market Growth Rate 2025-2033: 7.50% According to IMARC Group's latest research publication, "GCC Residential Real Estate Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC residential real estate market size was valued at USD 73.31 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 147.77 Billion by
GCC Drones Market Size to Surpass USD 2,005.3 Million by 2033 | With a 13.3% CAGR
GCC Drones Market Size to Surpass USD 2,005.3 Million by 2033 | With a 13.3% CAG …
GCC Drones Market Overview Market Size in 2024: USD 588.2 Million Market Size in 2033: USD 2,005.3 Million Market Growth Rate 2025-2033: 13.3% According to IMARC Group's latest research publication, "GCC Drones Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The GCC drones market size was valued at USD 588.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 2,005.3 Million by 2033, exhibiting a growth rate of
Medical Imaging Market to Surpass USD 70.8 Billion by 2033, at a CAGR of 5.03%
Medical Imaging Market to Surpass USD 70.8 Billion by 2033, at a CAGR of 5.03%
Market Overview: The medical imaging market is experiencing rapid growth, driven by Growing Burden of Chronic and Age-Related Diseases, Expansion of Government-Funded Health Infrastructure and Technological Advancements in Imaging Modalities. According to IMARC Group's latest research publication, "Medical Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global medical imaging market size reached USD 44.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach

All 5 Releases


More Releases for Cytokine

Cytokine Release Syndrome Market New Product Development & Latest Trends
Introduction Cytokine release syndrome (CRS) is a systemic inflammatory response triggered by an excessive activation of the immune system, leading to a surge of pro-inflammatory cytokines. While CRS can occur in severe infections and autoimmune conditions, it has gained heightened significance as a common and potentially life-threatening complication of advanced immunotherapies, particularly chimeric antigen receptor T-cell (CAR-T) therapy, bispecific antibodies, and immune checkpoint inhibitors. Symptoms range from fever, hypotension, and hypoxia to
Cytokine Release Syndrome Management Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Cytokine Release Syndrome Management Market - (By Cytokine Type (Tumor Necrosis Factor-TNF, Interleukins-II, Interferons-IFN, Epidermal Growth Factor-EGF), By Therapeutic Application (Cancer, Asthma, Airway Inflammation, Arthritis, Others), By Biomarker Type (Interleukin-10, Interleukin-6, Ferritin, Cluster of Differentiation-163), By Route of Administration (Oral, Intravenous), By End User (Hospitals, Specialty Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast
Emerging Trends Influencing The Growth Of The Cytokine Release Syndrome Treatmen …
The Cytokine Release Syndrome Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Cytokine Release Syndrome Treatment Market Size Expected to Be by 2034? The market size for the treatment of cytokine release syndrome has experienced remarkable growth recently. The market value
Cytokine Release Syndrome Management Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Cytokine Release Syndrome Management Market - (By Cytokine Type (Tumor Necrosis Factor-TNF, Interleukins-II, Interferons-IFN, Epidermal Growth Factor-EGF), By Therapeutic Application (Cancer, Asthma, Airway Inflammation, Arthritis, Others), By Biomarker Type (Interleukin-10, Interleukin-6, Ferritin, Cluster of Differentiation-163), By Route of Administration (Oral, Intravenous), By End User (Hospitals, Specialty Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast
Key Driver Shaping the Future Cytokine Release Syndrome Treatment Market From 20 …
What Is the Estimated Market Size and Growth Rate for the Cytokine Release Syndrome Treatment Market? In recent times, the market size for treatments of cytokine release syndrome has seen a rapid increase. The forecast predicts an upsurge from $1.25 billion in 2024 to $1.42 billion in 2025, presenting a compound annual growth rate (CAGR) of 13.7%. A growth surge during the historical period can be credited to factors such as
Cytokine Market Size, Share, Growth Report and Forecast 2024-2032
According to the report by Expert Market Research (EMR), the global cytokine market is projected to grow at a CAGR of 6% between 2024 and 2032. Aided by the burgeoning applications in medical and research fields, the market is expected to grow significantly by 2032. Cytokines are a broad category of small proteins that are crucial in cell signalling. Their role is primarily related to immune and inflammatory responses. These proteins